JUNIOR/SENIOR SCIENTIST, Immuno-Oncology
EMPLOYER: ViroMissile, Inc.
POSITION: Scientist, Immuno-Oncology
LOCATION: San Diego, CA; On-Site; Full Time
We are a clinical-stage biotech company that is committed to developing a new generation of intravenously deliverable oncolytic viruses with the goal of ultimately curing cancer, especially advanced cancer.
We are seeking a highly motivated Scientist with a proven track record of research accomplishments to join our growing cancer research team. The scientist will be part of a team dedicated to developing early and late-stage discovery programs in the field of Immuno-Oncology.
- Independently conceive and execute hypothesis driven research projects in the field of Immuno-Oncology
- Develop innovative in vivo/ex vivo/in vitro assays/analyses to interrogate the function of immune and tumor cell populations and their interactions
- Plan and execute experiments using good scientific judgment
- Make strong contributions to the research team’s short- and long-term scientific strategies
- Develop compelling scientific presentations and reports for internal review meetings, and external collaborators, scientific conferences and peer-reviewed journals
- PhD in immunology, molecular biology, cell biology, virology or related field with typically 0-6+ years of post-graduate experience
- Position will be filled at level commensurate with extent of education, experience, and accomplishment
- Broad expertise in cellular immunology, tumor immunology, and flow cytometry; extensive knowledge and experience developing, and testing the functional activity of T, B lymphocytes, Treg and NK cells.
- Good knowledge of molecular biology, oncology, virology; experience with anti-cancer drug candidates as it relates to oncolytic viruses.
- Cellular and/or tumor immunology principles, technologies, and experimental techniques (cell culture, in vitro cellular assays, ELISA, flow cytometry, etc.)
- Multi-parameter flow cytometry and proficiency in FACS data analysis programs Murine tumor models (genetically engineered, syngeneic, or humanized).
- Isolate and analyze the different immune cell populations from blood, tumor, spleen. Evaluating the oncolytic therapy capabilities of oncolytic viruses in in vitro and in vivo oncology models; involving clinical biomarker development.